Vitafoods Europe to examine mainstreaming of personalized nutrition

13 Dec 2017 --- One of the major issues to be discussed at Vitafoods Europe 2018 will be how personalized nutrition can break out of its niche and achieve mass market appeal, the organizers of the global nutraceutical event have announced. Advances in genomics and wearable technology have created new opportunities for products tailored to individual consumers. And in a new poll conducted by the organizers, personalized nutrition ranks as one of the most important industry trends for 2018, behind only clean label and scientifically supported health claims.

Enzymotec and Frutarom merger gets shareholder green light

12 Dec 2017 --- The shareholders of Israeli specialty chemicals company Enzymotec Ltd. have approved by large majority the merger transaction between Frutarom and Enzymotec. The transaction was approved at Enzymotec’s General Meeting by 99.9 percent majority of shareholders present at the meeting and entitled to vote, Frutarom Industries Ltd. reports.

Nutrition 21 launches US media campaign to support Velositol ingredient

11 Dec 2017 --- Nutrition 21, LLC has partnered with NYC-based media relations firm Pitch Publicity and clinical pharmacist James B. LaValle in a national media tour dedicated to educating consumers about the benefits of its proprietary ingredient, Velositol.

Pea stars for Roquette amid alternative protein boom

11 Dec 2017 --- Roquette’s range of pea proteins took a starring role at FiE 2017, and would seem to have a bright future in products promoted by the company. According to the company’s representatives, a key highlight of the company’s newest range of products is around plant-based proteins – many of which are based on pea proteins.

Inflammatory bowel disease rates on the rise outside West, says new study

08 Dec 2017 --- Countries in Africa, Asia, the Middle East and South America have seen a rise in incidence of inflammatory bowel disease as they have become increasingly industrialized and Westernized, a new study has found. The research – a collaboration between the University of Birmingham, UK, the University of Calgary, Canada, and the Chinese University of Hong Kong – is described by the University of Birmingham as the most definitive and comprehensive study of the global epidemiology of inflammatory bowel disease.

Consuming sugary drinks during pregnancy may increase asthma risk in mid-childhood

08 Dec 2017 --- Children between the ages of 7 and 9 may be at greater risk for developing asthma if they consumed high amounts of fructose in early childhood or their mothers drank a lot of sugar-sweetened beverages while pregnant, according to new research published online in the Annals of the American Thoracic Society.

NZMP develops innovative fast-digesting milk protein concentrate

08 Dec 2017 --- As part of its ongoing work in the areas of proteins and medical nutrition, Fonterra’s global dairy ingredients B2B brand NZMP has launched a new milk protein concentrate (MPC) coined SureProtein Fast MPC 4868. Compared to standard milk protein offerings, the ingredient is touted as being able to provide muscles with a higher level of amino acids within the first two hours of consumption and is absorbed as quickly as whey protein.

New Biopolis probiotic mix helps reduce topical steroid use by atopic dermatitis patients

07 Dec 2017 --- Biopolis, majority owned by agricultural processor and food ingredient provider Archer Daniels Midland Company (ADM), has introduced a new probiotic mix designed to reduce the need for topical steroid use by Atopic Dermatitis (AD) patients. The clinical research recently published in JAMA Dermatology, an international peer-reviewed general medical journal, shows the benefits of consuming a mix of probiotics in reducing the need for topical steroids by AD patients.

High PUFA levels in children linked to reduced allergy risk

07 Dec 2017 --- High levels of omega 3 and omega 6 polyunsaturated fatty acids in children’s blood are associated with a reduced risk of asthma or rhinitis at the age of 16 years, according to new research from Karolinska Institutet in Sweden. The study is published in The Journal of Allergy and Clinical Immunology.

One in four consumers spend less than five minutes on weekday breakfast: DSM survey

07 Dec 2017 --- DSM has found that one in four consumers spend less than five minutes on breakfast on weekdays, and half of consumers spend less than 15 minutes on breakfast. The findings are some of the results of DSM’s Breakfast Insights survey, which also include suggestions that the main reason for skipping breakfast is lack of time and consumers are paying more attention to the lack of sugar in their breakfast.

Weight management program can put Type 2 diabetes into remission finds Lancet study

06 Dec 2017 --- Type 2 diabetes can be reversed following an intensive weight management program, according to a randomized trial in adults who have had the condition for up to six years, published in The Lancet. The findings lend support to the widespread use of this type of intervention in the routine care of Type 2 diabetes across health services.

Kappa Bioscience reveals free vitamin K2 MK-7 quality testing program

06 Dec 2017 --- Kappa Bioscience has announced the worldwide launch of a free vitamin K2 MK-7 quality testing program. The program, announced at CPhI India, is open to finished K2 products, from any source, for testing and verification of the product’s K2 label claim. The program supports wider goals of educating markets about K2 stability and advancing K2 science to resolve the question of why unprotected K2 is unstable in mineral formulations. 

Exercise changes gut microbiota independent of diet, researchers report

05 Dec 2017 --- Exercise alone can change the composition of microbes in the gut, according to two studies – one in mice and the other in human subjects. The studies, which offer the first definitive evidence of the hypothesis, were designed to isolate exercise-induced changes from other factors – such as diet or antibiotic use – that might alter the intestinal microbiota.

Novel seaweed extracts: Cancer-inhibiting properties discovered in fucoidans

05 Dec 2017 --- Breakthrough research has confirmed that two unique compounds extracted from a specific seaweed have significant cancer-inhibiting properties. A series of animal studies undertaken at McGovern Medical School, University of Texas Health Science Center in Houston (UTHealth) have shown that the two fucoidans reduced tumor growth in select cancers and significantly improved the effectiveness of the common chemotherapy drug tamoxifen.

Scientists find natural mimetics of anti-cancer and anti-aging drugs

04 Dec 2017 --- Researchers from the Biogerontology Research Foundation in the UK, Insilico Medicine, Life Extension and other institutions have announced the publication of a landmark study in the journal Aging on the identification of natural mimetics of metformin and rapamycin.

Cardiovascular risk in diabetes can be reduced using hormones, claims study

04 Dec 2017 --- Scientists at Joslin Diabetes Center in the US have taken another step toward solving a long-standing puzzle about heart health in Type 2 diabetes, with a finding that eventually may point towards more personalized patient care. Genetic analysis has linked the hormone known as glucagon-like peptide 1 (GLP-1) with cardiovascular mortality risks.

US arthritis numbers much higher than current estimates, new research indicates

27 Nov 2017 --- The prevalence of arthritis in the United States has been substantially underestimated, especially among adults over 65 years old, according to new research. The Arthritis & Rheumatology findings indicate that research is needed to better monitor arthritis prevalence in the US population and to develop better prevention strategies.

Synthetic antioxidant l-ergothioneine safe as a novel food for pregnant women and children: EFSA

24 Nov 2017 --- The European Food Safety Authority (EFSA) Panel on Dietetic Products, Nutrition and Allergies (NDA) has concluded that synthetic l-ergothioneine is safe under the proposed uses and use levels for the groups of the population which had been excluded by the applicant in the original application. Following a request from the European Commission, EFSA confirmed the safety of the powerful antioxidant for groups including infants, young children (i.e. toddlers), pregnant women and breastfeeding women.

Fibers and proteins among Naturex’s expansion and diversification strategy

24 Nov 2017 --- Over the past months, Naturex has moved to boost its presence in the natural nutrition market with the acquisition of Swedish Oat Fiber, a specialized manufacturer of oat dietary fibers, oils and proteins, as well as the signing of a global distribution agreement via its Open Innovation program (Ingenium) with a Colorado-based start-up, MycoTechnology, for their PureTaste, shiitake mushroom plant protein created by patent-pending fungi fermentation technology.

A&B achieves probiotic patent for treatment of chronic digestive diseases

22 Nov 2017 --- A&B Ingredients’ probiotic PA5051 has been issued a new patent as a method for treatment of chronic digestive diseases. The new patent covers both inflammatory bowel disorder (IBD) and nonspecific enteropathy (NEP), and can be used as a treatment for both humans and animals.

loading